CEACAM4 Antibody (822608) [DyLight 405]
Novus Biologicals, part of Bio-Techne | Catalog # FAB7845E
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
DyLight 405 (Excitation = 400 nm, Emission = 420 nm)
Antibody Source
Recombinant Monoclonal Mouse IgG2B Clone # 822608
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human CEACAM-4
Phe36-Val140
Accession # O75871
Phe36-Val140
Accession # O75871
Specificity
Detects human CEACAM-4 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for CEACAM4 Antibody (822608) [DyLight 405]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CEACAM-4
Long Name
Carcinoembryonic Antigen-related Cell Adhesion Molecule 4
Alternate Names
CEACAM4, CGM7
Gene Symbol
CEACAM4
Additional CEACAM-4 Products
Product Documents for CEACAM4 Antibody (822608) [DyLight 405]
Product Specific Notices for CEACAM4 Antibody (822608) [DyLight 405]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...